Link Pharma Chem Intrinsic Value
Link Pharma Chem (LINKPH) median intrinsic value is ₹46.42 from 4 valuation models (range ₹30–₹56), vs current price ₹27.86 — +66.6% upside (Trading Below Calculated Value), margin of safety 40.0%. For current market price and key ratios, visit Link Pharma Chem stock price NSE.
LINKPH Valuation Methods Summary — DCF, Graham Number & P/E
Link Pharma Chem intrinsic value across 4 models vs current price ₹27.86 — upside/downside and value range per method. See LINKPH book value to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹32.50 | ₹29.25 - ₹35.75 | +16.7% | Book Value/Share: ₹32.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹55.72 | ₹50.15 - ₹61.29 | +100.0% | Revenue/Share: ₹72.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹30.00 | ₹27.00 - ₹33.00 | +7.7% | EBITDA: ₹2.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹46.42 | ₹37.14 - ₹55.70 | +66.6% | CF Growth: 5.0%, Discount: 15% |
LINKPH Intrinsic Value vs Market Price — All Valuation Models
Link Pharma Chem fair value range ₹30–₹56 vs current market price ₹27.86 across 4 valuation models. Check LINKPH company valuation to track the company's total market size over time.
LINKPH Intrinsic Value Analysis — Undervalued or Overvalued?
Link Pharma Chem median intrinsic value ₹46.42, current price ₹27.86 — Trading Below Calculated Value by 66.6%, margin of safety 40.0%.
What is the intrinsic value of LINKPH?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Link Pharma Chem (LINKPH) is ₹46.42 (median value). With the current market price of ₹27.86, this represents a +66.6% variance from our estimated fair value.
The valuation range spans from ₹30.00 to ₹55.72, indicating ₹30.00 - ₹55.72.
Is LINKPH undervalued or overvalued?
Based on our multi-method analysis, Link Pharma Chem (LINKPH) appears to be trading below calculated value by approximately 66.6%.
LINKPH Financial Health — Key Ratios vs Industry Benchmarks
Link Pharma Chem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 11.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.16x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
LINKPH Cash Flow Quality — Operating & Free Cash Flow
Link Pharma Chem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-4 Cr | Negative Cash Flow | 3/10 |